Helen of Troy Limited (HELE) 10-Q 6 Oct 22 2023 Q2 Quarterly report Financial data

Cover page

Cover page - shares	6 Months Ended
	Aug. 31, 2022	Sep. 29, 2022
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Aug. 31, 2022
Document Transition Report	false
Entity File Number	001-14669
Entity Registrant Name	HELEN OF TROY LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	74-2692550
Entity Address, Address Line One	1 Helen of Troy Plaza
Entity Address, City or Town	El Paso
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	79912
City Area Code	915
Local Phone Number	225-8000
Title of 12(b) Security	Common Shares, $0.10 par value per share
Trading Symbol	HELE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,990,074
Entity Central Index Key	0000916789
Current Fiscal Year End Date	--02-28
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Other Address
Entity Addresses [Line Items]
Entity Address, Address Line One	Clarendon House
Entity Address, Address Line Two	2 Church Street
Entity Address, City or Town	Hamilton
Entity Address, Country	BM

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Assets, current:
Cash and cash equivalents	$ 39,650	$ 33,381
Receivables - principally trade, less allowances of $1,718 and $843	507,261	457,623
Inventory	643,192	557,992
Prepaid expenses and other current assets	34,647	25,712
Income taxes receivable	13,066	5,430
Assets held for sale	0	1,942
Total assets, current	1,237,816	1,082,080
Property and equipment, net of accumulated depreciation of $173,614 and $161,006	306,340	205,378
Goodwill	1,065,214	948,873
Other intangible assets, net of accumulated amortization of $159,261 and $150,309	562,751	537,846
Operating lease assets	40,940	37,759
Deferred tax assets, net	2,657	3,628
Other assets	9,490	7,887
Total assets	3,225,208	2,823,451
Liabilities, current:
Accounts payable, principally trade	311,622	308,178
Accrued expenses and other current liabilities	235,133	271,675
Income taxes payable	15,484	20,718
Long-term debt, current maturities	20,872	1,884
Liabilities held for sale	0	235
Total liabilities, current	583,111	602,690
Long-term debt, excluding current maturities	1,148,870	811,332
Lease liabilities, non-current	45,630	43,745
Deferred tax liabilities, net	34,643	21,582
Other liabilities, non-current	14,608	16,763
Total liabilities	1,826,862	1,496,112
Commitments and contingencies
Stockholders' equity:
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued	0	0
Common stock, $0.10 par. Authorized 50,000,000 shares; 23,968,992 and 23,800,305 shares issued and outstanding	2,397	2,380
Additional paid in capital	312,567	303,740
Accumulated other comprehensive income	7,200	202
Retained earnings	1,076,182	1,021,017
Total stockholders' equity	1,398,346	1,327,339
Total liabilities and stockholders' equity	$ 3,225,208	$ 2,823,451

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Statement of Financial Position [Abstract]
Allowance on receivables	$ 1,718	$ 843
Property and equipment, accumulated depreciation	173,614	161,006
Other intangible assets, accumulated amortization	$ 159,261	$ 150,309
Cumulative preferred stock, nonvoting, par value (in dollars per share)	$ 1	$ 1
Cumulative preferred stock, non-voting, authorized shares (in shares)	2,000,000	2,000,000
Cumulative preferred stock, non-voting, issued shares (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, authorized shares (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	23,968,992	23,800,305
Common stock, shares outstanding (in shares)	23,968,992	23,800,305

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Income Statement [Abstract]
Sales revenue, net	$ 521,400	$ 475,228	$ 1,029,478	$ 1,016,451
Cost of goods sold	299,954	264,640	596,861	585,271
Gross profit	221,446	210,588	432,617	431,180
Selling, general and administrative expense (“SG&A”)	169,724	142,928	346,954	298,679
Restructuring charges	4,776	369	4,778	375
Operating income	46,946	67,291	80,885	132,126
Non-operating income, net	113	31	180	133
Interest expense	9,166	3,307	13,539	6,302
Income before income tax	37,893	64,015	67,526	125,957
Income tax expense	7,221	12,700	12,259	17,670
Net income	$ 30,672	$ 51,315	$ 55,267	$ 108,287
Earnings per share (“EPS”):
Basic (in dollars per share)	$ 1.28	$ 2.13	$ 2.31	$ 4.47
Diluted (in dollars per share)	$ 1.28	$ 2.11	$ 2.29	$ 4.42
Weighted average shares used in computing EPS:
Basic (in shares)	23,969	24,101	23,917	24,225
Diluted (in shares)	24,056	24,347	24,089	24,492

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 30,672	$ 51,315	$ 55,267	$ 108,287
Other comprehensive income, net of tax:
Cash flow hedge activity - interest rate swaps	1,301	1,079	3,507	1,836
Cash flow hedge activity - foreign currency contracts	2,538	5,163	3,491	3,609
Total other comprehensive income, net of tax	3,839	6,242	6,998	5,445
Comprehensive income	$ 34,511	$ 57,557	$ 62,265	$ 113,732

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive (Loss) Income	Retained Earnings
Beginning balance (in shares) at Feb. 28, 2021		24,406
Beginning balance at Feb. 28, 2021	$ 1,239,347	$ 2,441	$ 283,396	$ (11,656)	$ 965,166
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	56,972				56,972
Other comprehensive loss, net of tax	(797)			(797)
Exercise of stock options (in shares)		4
Exercise of stock options	275		275
Issuance and settlement of restricted stock (in shares)		177
Issuance and settlement of restricted stock	0	$ 18	(18)
Issuance of common stock related to stock purchase plan (in shares)		13
Issuance of common stock related to stock purchase plan	2,338	$ 1	2,337
Common stock repurchased and retired (in shares)		(502)
Common stock repurchased and retired	(110,074)	$ (50)	(16,616)		(93,408)
Share-based compensation	14,020		14,020
Ending balance (in shares) at May. 31, 2021		24,098
Ending balance at May. 31, 2021	1,202,081	$ 2,410	283,394	(12,453)	928,730
Beginning balance (in shares) at Feb. 28, 2021		24,406
Beginning balance at Feb. 28, 2021	1,239,347	$ 2,441	283,396	(11,656)	965,166
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss, net of tax	5,445
Ending balance (in shares) at Aug. 31, 2021		24,105
Ending balance at Aug. 31, 2021	1,267,822	$ 2,411	291,589	(6,211)	980,033
Beginning balance (in shares) at May. 31, 2021		24,098
Beginning balance at May. 31, 2021	1,202,081	$ 2,410	283,394	(12,453)	928,730
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	51,315				51,315
Other comprehensive loss, net of tax	6,242			6,242
Exercise of stock options (in shares)		6
Exercise of stock options	520	$ 1	519
Issuance and settlement of restricted stock (in shares)		2
Common stock repurchased and retired (in shares)		(1)
Common stock repurchased and retired	(116)		(104)		(12)
Share-based compensation	7,780		7,780
Ending balance (in shares) at Aug. 31, 2021		24,105
Ending balance at Aug. 31, 2021	1,267,822	$ 2,411	291,589	(6,211)	980,033
Beginning balance (in shares) at Feb. 28, 2022		23,800
Beginning balance at Feb. 28, 2022	1,327,339	$ 2,380	303,740	202	1,021,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	24,595				24,595
Other comprehensive loss, net of tax	3,159			3,159
Exercise of stock options (in shares)		8
Exercise of stock options	659	$ 1	658
Issuance and settlement of restricted stock (in shares)		235
Issuance and settlement of restricted stock	0	$ 24	(24)
Issuance of common stock related to stock purchase plan (in shares)		13
Issuance of common stock related to stock purchase plan	2,275	$ 1	2,274
Common stock repurchased and retired (in shares)		(89)
Common stock repurchased and retired	(18,224)	$ (9)	(18,113)		(102)
Share-based compensation	16,619		16,619
Ending balance (in shares) at May. 31, 2022		23,967
Ending balance at May. 31, 2022	1,356,422	$ 2,397	305,154	3,361	1,045,510
Beginning balance (in shares) at Feb. 28, 2022		23,800
Beginning balance at Feb. 28, 2022	1,327,339	$ 2,380	303,740	202	1,021,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss, net of tax	6,998
Ending balance (in shares) at Aug. 31, 2022		23,969
Ending balance at Aug. 31, 2022	1,398,346	$ 2,397	312,567	7,200	1,076,182
Beginning balance (in shares) at May. 31, 2022		23,967
Beginning balance at May. 31, 2022	1,356,422	$ 2,397	305,154	3,361	1,045,510
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	30,672				30,672
Other comprehensive loss, net of tax	3,839			3,839
Issuance and settlement of restricted stock (in shares)		2
Issuance and settlement of restricted stock	(1)		(1)
Common stock repurchased and retired	(81)		(81)
Share-based compensation	7,495		7,495
Ending balance (in shares) at Aug. 31, 2022		23,969
Ending balance at Aug. 31, 2022	$ 1,398,346	$ 2,397	$ 312,567	$ 7,200	$ 1,076,182

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Cash used by operating activities:
Net income	$ 55,267	$ 108,287
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	21,617	17,441
Amortization of financing costs	512	489
Non-cash operating lease expense	5,186	4,434
Provision for credit losses	963	510
Non-cash share-based compensation	24,114	21,800
Gain on sale of Personal Care business	(1,336)	(513)
Gain on the sale or disposal of property and equipment	(20)	(1,640)
Deferred income taxes and tax credits	3,977	(8,207)
Changes in operating capital, net of effects of acquisitions of businesses:
Receivables	(46,754)	(62,604)
Inventory	(77,348)	(124,506)
Prepaid expenses and other current assets	575	(4,982)
Other assets and liabilities, net	(2,040)	(4,545)
Accounts payable	3,333	6,080
Accrued expenses and other current liabilities	(43,767)	(26,414)
Accrued income taxes	(19,731)	16,032
Net cash used by operating activities	(75,452)	(58,338)
Cash (used) provided by investing activities:
Capital and intangible asset expenditures	(112,635)	(23,954)
Net payments to acquire businesses, net of cash acquired	(148,111)	0
Proceeds from sale of Personal Care business	1,804	44,700
Proceeds from the sale of property and equipment	20	3,208
Net cash (used) provided by investing activities	(258,922)	23,954
Cash provided by financing activities:
Proceeds from revolving loans	573,500	342,500
Repayment of line of credit	(465,000)	(212,500)
Proceeds from term loans	250,000	0
Repayment of long-term debt	(1,900)	(1,900)
Payment of financing costs	(586)	0
Proceeds from share issuances under share-based compensation plans	2,934	3,133
Payments for repurchases of common stock	(18,305)	(110,190)
Net cash provided by financing activities	340,643	21,043
Net increase (decrease) in cash and cash equivalents	6,269	(13,341)
Cash and cash equivalents, beginning balance	33,381	45,120
Cash and cash equivalents, ending balance	39,650	31,779
Supplemental non-cash investing activity:
Capital expenditures included in accounts payable	$ 8,484	$ 2,927

Basis of Presentation and Relat

Basis of Presentation and Related Information	6 Months Ended
	Aug. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Related Information	Note 1 - Basis of Presentation and Related Information Corporate Overview The accompanying condensed consolidated financial statements contain all adjustments (consisting of normal recurring adjustments) necessary to present fairly our consolidated financial position as of August 31, 2022 and February 28, 2022, and the results of our consolidated operations for the interim periods presented. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2022 (“Form 10-K”), and our other reports on file with the Securities and Exchange Commission (the “SEC”). When used in these notes, unless otherwise indicated or the context suggests otherwise, references to “the Company”, “our Company”, “Helen of Troy”, “we”, “us”, or “our” refer to Helen of Troy Limited and its subsidiaries, which are all wholly-owned. We refer to our common shares, par value $0.10 per share, as “common stock.” References to “the FASB” refer to the Financial Accounting Standards Board. References to “GAAP” refer to accounting principles generally accepted in the United States of America (the “U.S.”). References to “ASU” refer to the codification of GAAP in the Accounting Standards Updates issued by the FASB. References to “ASC” refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB. We incorporated as Helen of Troy Corporation in Texas in 1968 and were reorganized as Helen of Troy Limited in Bermuda in 1994. We are a leading consumer products company offering creative products and solutions for our customers through a diversified portfolio of brands. As of August 31, 2022, we operated three segments: Home & Outdoor, Health & Wellness, and Beauty. Our Home & Outdoor segment provides a broad range of innovative consumer products for home activities such as food preparation, cooking, cleaning and organization, as well as products for outdoor and on the go activities such as hydration, food storage, backpacks, and travel gear. The Health & Wellness segment provides health and wellness products including healthcare devices, thermometers, water and air filtration systems, humidifiers, and fans. Our Beauty segment provides mass and prestige market beauty appliances including hair styling appliances, grooming tools, decorative hair accessories, and prestige market liquid-based hair and personal care products. Our business is seasonal due to different calendar events, holidays and seasonal weather patterns. Our fiscal reporting period ends on the last day in February. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico, Vietnam and the U.S. During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our Beauty segment's mass channel personal care business, which included liquid, powder and aerosol products under brands such as Pert, Brut, Sure and Infusium (“Personal Care”). On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million. See Note 3 for additional information. On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand (“Curlsmith”). The total purchase consideration was $149.7 million in cash, net of a preliminary closing net working capital adjustment and cash acquired. See Note 4 for additional information. On December 29, 2021, we completed the acquisition of Osprey Packs, Inc. (“Osprey”), a longtime U.S. leader in technical and everyday packs, for $409.3 million in cash, net of a final net working capital adjustment and cash acquired. Osprey is highly respected in the outdoor industry with a product lineup that includes a wide range of backpacks and daypacks for hiking, mountaineering, skiing, climbing, mountain biking, trail running, commuting, and school, as well as rugged adventure travel packs, wheeled luggage, and travel accessories. See Note 4 for additional information. Macroeconomic trends and the COVID-19 pandemic have adversely impacted our business in the first and second quarters of fiscal 2023. In response to rising inflation, the Federal Open Market Committee has been raising interest rates, and has stated it intends to continue to raise rates throughout the remainder of 2022 and possibly into 2023. As a result, we incurred higher average interest rates compared to the same period last year, and we expect this trend to continue throughout fiscal year 2023. While the actual timing and extent of the future increases in interest rates remains unknown, higher long-term interest rates are expected to significantly increase interest expense on our outstanding debt. High inflation and interest rates have also negatively impacted consumer disposable income, credit availability and spending, among others things, and may continue to have an adverse impact throughout fiscal year 2023. Surges in demand and shifts in shopping patterns related to COVID-19, as well as other factors, have strained the global freight network, which has resulted in higher costs, less capacity, component part and raw material shortages, and longer lead times. The extent of COVID-19’s impact on the demand for certain of our product lines in the future will depend on continuing future developments, including any new variants and surges in the spread of COVID-19, our continued ability to source and distribute our products, the impact of COVID-19 on capital and financial markets, and the related impact on consumer confidence and spending, all of which are uncertain and difficult to predict considering the continuously evolving landscape. Accordingly, our liquidity and financial results could be impacted in ways that we are not able to predict today. Principles of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation. The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

New Accounting Pronouncements

New Accounting Pronouncements	6 Months Ended
	Aug. 31, 2022
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	Note 2 - New Accounting Pronouncements There have been no changes in the information provided in our Form 10-K.

Assets and Liabilities Held for

Assets and Liabilities Held for Sale	6 Months Ended
	Aug. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Assets and Liabilities Held for Sale	Note 3 - Assets and Liabilities Held for Sale During the fourth quarter of fiscal 2020, we committed to a plan to divest certain assets within our Personal Care business and accordingly, we classified the identified net assets of the disposal group as held for sale. On June 7, 2021, we completed the sale of our North America Personal Care business to HRB Brands LLC, for $44.7 million in cash and recognized a gain on the sale in SG&A totaling $0.5 million. On March 25, 2022, we completed the sale of the Latin America and Caribbean Personal Care business to HRB Brands LLC, for $1.8 million in cash and recognized a gain on the sale in SG&A totaling $1.3 million. The net assets sold included intangible assets, inventory, certain net trade receivables, fixed assets and certain accrued sales discounts and allowances relating to our Personal Care business. As a result of these dispositions, we no longer have any assets or liabilities classified as held for sale. The carrying amounts of the major classes of assets and liabilities for our Personal Care business that were classified as held for sale were as follows: (in thousands) February 28, 2022 Receivables, net of allowance of $23 $ 1,265 Inventory 611 Property and equipment, net of accumulated depreciation of $152 66 Assets held for sale $ 1,942 Accrued sales discounts and allowances $ 235 Liabilities held for sale $ 235

Acquisitions

Acquisitions	6 Months Ended
	Aug. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Note 4 - Acquisitions Curlsmith On April 22, 2022, we completed the acquisition of Recipe Products Ltd., a producer of innovative prestige hair care products for all types of curly and wavy hair under the Curlsmith brand. Curlsmith's products are a category leader in the market for prestige haircare products for curly hair and include conditioners, shampoos and co-washes purposefully designed for the unique joys and challenges of all types of curls and textured hair. The Curlsmith brand and products were added to the Beauty segment. The total purchase consideration was $149.7 million in cash, net of a preliminary closing net working capital adjustment of $0.3 million and cash acquired. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $2.7 million during the six months ended August 31, 2022, which were recognized in SG&A within our condensed consolidated statement of income. We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our Beauty segment's existing marketing and sales structure, as well as our global sourcing, distribution, shared service, and international go-to-market capabilities. The goodwill is not expected to be deductible for income tax purposes. We have provisionally determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $21.0 million to trade names and are amortizing over a 20 year expected life. We assigned $12.0 million to customer relationships and are amortizing over a 19.5 year expected life, based on historical attrition rates. During the second quarter of fiscal 2023, we made adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill of $0.1 million. The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 4,211 Inventory 7,890 Prepaid expenses and other current assets 119 Property and equipment 212 Goodwill 118,613 Trade names - definite 21,000 Customer relationships - definite 12,000 Deferred tax assets, net 360 Total assets 164,405 Liabilities: Accounts payable 1,401 Accrued expenses and other current liabilities 2,583 Income taxes payable 2,538 Deferred tax liabilities, net 8,187 Total liabilities 14,709 Net assets recorded $ 149,696 Both the fair value and gross contractual amount of receivables acquired was $4.2 million, as an immaterial amount is expected to be uncollectible. The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows: (in thousands, except earnings per share data) Three Months Ended Six Months Ended Sales revenue, net $ 10,207 $ 13,453 Net income 1,437 1,876 EPS: Basic $ 0.06 $ 0.08 Diluted $ 0.06 $ 0.08 (1) Represents approximately nineteen weeks of operating results from Curlsmith, acquired on April 22, 2022. The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and would not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results. Three Months Ended Six Months Ended (in thousands, except earnings per share data) 2022 2021 2022 2021 Sales revenue, net $ 521,400 $ 483,586 $ 1,036,570 $ 1,034,443 Net income 30,672 52,156 57,180 107,260 EPS: Basic $ 1.28 $ 2.16 $ 2.39 $ 4.43 Diluted $ 1.28 $ 2.14 $ 2.37 $ 4.38 These amounts have been calculated after applying our accounting policies and adjusting the results of Curlsmith to reflect the effect of definite-lived intangible assets recognized as part of the business combination on amortization expense as if the acquisition had occurred on March 1, 2021. Osprey On December 29, 2021, we completed the acquisition of Osprey, a longtime U.S. leader in technical and everyday packs. Osprey is highly respected in the outdoor industry with a product lineup that includes a wide range of backpacks and daypacks for hiking, mountaineering, skiing, climbing, mountain biking, trail running, commuting, and school, as well as rugged adventure travel packs, wheeled luggage, and travel accessories. The Osprey brand and products were added to the Home & Outdoor segment. The total purchase consideration, net of cash acquired, was $409.3 million in cash, including the impact of a final $10.7 million favorable net working capital adjustment. The acquisition was funded with cash on hand and borrowings under our existing revolving credit facility. We incurred pre-tax acquisition-related expenses of $0.1 million during the six months ended August 31, 2022, which were recognized in SG&A within our condensed consolidated statement of income. We accounted for the acquisition as a purchase of a business and recorded the excess of the purchase price over the estimated fair value of the assets acquired and liabilities assumed as goodwill. The goodwill recognized is attributable primarily to expected synergies including leveraging our information systems, shared service capabilities and international footprint. The goodwill is not expected to be deductible for income tax purposes. We have provisionally determined the appropriate fair values of the acquired intangible assets and completed our analysis of the economic lives of the assets acquired. We assigned $170.0 million to trade names which were determined to have an indefinite life. We assigned $22.0 million to customer relationships and are amortizing over a 4.5 year expected life, based on historical attrition rates. During the first quarter of fiscal 2023, we finalized the net working capital adjustment, which resulted in a $1.6 million reduction to the total purchase consideration and we reduced the provisional accounts payable liability by $0.7 million, both with a corresponding decrease to goodwill totaling $2.3 million. During the second quarter of fiscal 2023, we made immaterial adjustments to provisional asset and liability balances, which resulted in a corresponding net increase to goodwill. The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 11,758 Inventory 30,056 Prepaid expenses and other current assets 3,699 Income taxes receivable 4,169 Property and equipment 11,386 Goodwill 206,699 Trade names - indefinite 170,000 Customer relationships - definite 22,000 Operating lease assets 2,155 Total assets 461,922 Liabilities: Accounts payable 3,780 Accrued expenses and other current liabilities 7,334 Lease liabilities, non-current 1,719 Deferred tax liabilities, net 39,794 Total liabilities 52,627 Net assets recorded $ 409,295

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Aug. 31, 2022
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Note 5 - Accrued Expenses and Other Current Liabilities A summary of accrued expenses and other current liabilities was as follows: (in thousands) August 31, 2022 February 28, 2022 Accrued compensation, benefits and payroll taxes $ 20,643 $ 55,405 Accrued sales discounts and allowances 72,380 69,120 Accrued sales returns 29,639 33,384 Accrued advertising 54,591 55,775 Other 57,880 57,991 Total accrued expenses and other current liabilities $ 235,133 $ 271,675

Share-Based Compensation Plans

Share-Based Compensation Plans	6 Months Ended
	Aug. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation Plans	Note 6 - Share-Based Compensation Plans As part of our compensation structure, we grant share-based compensation awards to certain employees and non-employee members of our Board of Directors during the fiscal year. These awards may be subject to attainment of certain service conditions, performance conditions and/or market conditions. During the first quarter of fiscal 2023, we granted 36,088 service condition awards (“Service Condition Awards”) with a weighted average grant date fair value of $204.11. Additionally, we granted 165,734 performance-based awards during the first quarter of fiscal 2023, of which 82,867 contained performance conditions (“Performance Condition Awards”) and 82,867 contained market conditions (“Market Condition Awards”), with weighted average grant date fair values of $204.11 and $152.91, respectively. Refer to our Form 10-K for further information on the Company's share-based compensation plans. We recorded share-based compensation expense in SG&A as follows: Three Months Ended August 31, Six Months Ended (in thousands) 2022 2021 2022 2021 Directors stock compensation $ 222 $ 163 $ 395 $ 323 Service Condition Awards 2,160 3,296 5,277 5,236 Performance Condition Awards 3,196 3,061 14,041 13,084 Market Condition Awards 1,917 1,260 3,827 2,389 Employee stock purchase plan — — 574 768 Share-based compensation expense 7,495 7,780 24,114 21,800 Less income tax benefits (570) (712) (1,654) (1,571) Share-based compensation expense, net of income tax benefits $ 6,925 $ 7,068 $ 22,460 $ 20,229 Unrecognized Share-Based Compensation Expense As of August 31, 2022, our total unrecognized share-based compensation for all awards was $50.8 million, which will be recognized over a weighted average amortization period of 2.1 years. The total unrecognized share-based compensation reflects an estimate of target achievement for Performance Condition Awards granted during the first quarter of fiscal 2023 and fiscal 2022, and a weighted average estimate of 150% of target achievement for Performance Condition Awards granted in fiscal 2021.

Repurchases of Common Stock

Repurchases of Common Stock	6 Months Ended
	Aug. 31, 2022
Equity [Abstract]
Repurchases of Common Stock	Note 7 - Repurchases of Common Stock In August 2021, our Board of Directors authorized the repurchase of up to $500 million of our outstanding common stock. The authorization became effective August 25, 2021, for a period of three years, and replaced our former repurchase authorization. As of August 31, 2022, our repurchase authorization allowed for the purchase of $403.7 million of common stock. Our current equity-based compensation plans include provisions that allow for the “net exercise” of share-settled awards by all plan participants. In a net exercise, any required payroll taxes, federal withholding taxes and exercise price of the shares due from the option or other share-based award holders are settled by having the holder tender back to us a number of shares at fair value equal to the amounts due. Net exercises are treated as purchases and retirements of shares. The following table summarizes our share repurchase activity for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands, except share and per share data) 2022 2021 2022 2021 Common stock repurchased on the open market: Number of shares — — — 436,842 Aggregate value of shares $ — $ — $ — $ 95,484 Average price per share $ — $ — $ — $ 218.58 Common stock received in connection with share-based compensation: Number of shares 501 503 89,959 66,147 Aggregate value of shares $ 81 $ 116 $ 18,305 $ 14,706 Average price per share $ 163.28 $ 229.76 $ 203.49 $ 222.32

Restructuring Plan

Restructuring Plan	6 Months Ended
	Aug. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring Plan	Note 8 - Restructuring Plan During the second quarter of fiscal 2023, we focused on developing a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and reduce costs (referred to as “Project Pegasus”). Project Pegasus includes initiatives to further optimize our brand portfolio, streamline and simplify the organization, accelerate cost of goods savings projects, enhance the efficiency of our supply chain network, optimize our indirect spending, and improve our cash flow and working capital, as well as other activities. We anticipate these initiatives will create operating efficiencies, as well as provide a platform to fund future growth investments. We have the following expectations regarding Project Pegasus: • Targeted annualized pre-tax operating profit improvements of approximately $75 million to $85 million, which we expect to begin in fiscal 2024 and be substantially achieved by the end of fiscal 2026. • Estimated cadence of the recognition of the savings will be approximately 25% in fiscal 2024, approximately 50% in fiscal 2025 and approximately 25% in fiscal 2026. • Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A. • Total one-time pre-tax restructuring charges of approximately $85 million to $95 million over the duration of the plan, which is expected to be completed during fiscal 2025 and will primarily be comprised of severance and employee related costs, professional fees, contract termination costs, and other exit and disposal costs. • All of our operating segments and shared services will be impacted by the plan. During both the three and six month periods ended August 31, 2022, we incurred $4.8 million of pre-tax restructuring costs in connection with Project Pegasus, which are recorded as “Restructuring charges” in the condensed consolidated statements of income. We recognized $0.4 million of pre-tax restructuring costs during both the three and six month periods ended August 31, 2021, under a prior restructuring plan referred to as Project Refuel, which was completed during the fourth quarter of fiscal 2022. The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented: Three Months Ended August 31, 2022 (in thousands) Home & Health & Beauty Total Severance and employee related costs $ 472 $ 1,926 $ 443 $ 2,841 Professional fees — 128 — 128 Contract termination — 1,500 — 1,500 Other — — 307 307 Total restructuring charges $ 472 $ 3,554 $ 750 $ 4,776 Six Months Ended August 31, 2022 Total (in thousands) Home & Health & Beauty Total Severance and employee related costs $ 472 $ 1,926 $ 445 $ 2,843 $ 2,843 Professional fees — 128 — 128 128 Contract termination — 1,500 — 1,500 1,500 Other — — 307 307 307 Total restructuring charges $ 472 $ 3,554 $ 752 $ 4,778 $ 4,778 The table below presents a rollforward of our accruals related to Project Pegasus, which are included in accrued expenses and other current liabilities: (in thousands) Balance at February 28, 2022 Charges Payments Balance at August 31, 2022 Severance and employee related costs $ — $ 2,843 $ 802 $ 2,041 Professional fees — 128 128 — Contract termination — 1,500 — 1,500 Other — 307 307 — Total $ — $ 4,778 $ 1,237 $ 3,541

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9 - Commitments and Contingencies Legal Matters We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity, except as described below. On December 23, 2021, Brita LP filed a complaint against Kaz USA, Inc. and Helen of Troy Limited in the United States District Court for the Western District of Texas (the “Patent Litigation”), alleging patent infringement by the Company relating to its PUR gravity-fed water filtration systems. In the Patent Litigation, Brita LP seeks monetary damages and injunctive relief relating to the alleged infringement. Brita LP simultaneously filed a complaint with the United States International Trade Commission (“ITC”) against Kaz USA, Inc., Helen of Troy Limited and five other companies that sell water filtration systems (the “ITC Action”). The complaint in the ITC Action also alleges patent infringement by the Company with respect to a limited set of PUR gravity-fed water filtration systems. In the ITC Action, Brita LP requested the ITC to initiate an unfair import investigation relating to such filtration systems. This action seeks injunctive relief to prevent entry of PUR products (and certain other products) into the U.S. and removal of existing inventory that is already in the U.S. On January 25, 2022, the ITC instituted the investigation requested by the ITC Action. In August 2022, the parties participated in the evidentiary hearing (“ITC Trial”) and are awaiting a final opinion. The Patent Litigation has been stayed pending resolution of the ITC Action. We intend to vigorously pursue our claims and defenses in these proceedings. However, we cannot predict the outcome of these proceedings, the amount or range of any potential loss, or when the proceedings will be resolved. Litigation is inherently unpredictable, and the resolution or disposition of these proceedings could, if adversely determined, have a material and adverse impact on our financial position and results of operations. Regulatory Matters Our operations are subject to national, state, local, and provincial jurisdictions' environmental, health and safety laws and regulations and industry-specific product certifications. Many of the products we sell are subject to product safety laws and regulations in various jurisdictions. These laws and regulations specify the maximum allowable levels of certain materials that may be contained in our products, provide statutory prohibitions against misbranded and adulterated products, establish ingredients and manufacturing procedures for certain products, specify product safety testing requirements, and set product identification, labeling and claim requirements. Additionally, some product lines within our Health & Wellness segment are subject to product identification, labeling and claim requirements, which are monitored and enforced by regulatory agencies, such as the U.S. Environmental Protection Agency (the “EPA”), U.S. Customs and Border Protection, the U.S. Food and Drug Administration, and the U.S. Consumer Product Safety Commission. During fiscal 2022, we were in discussions with the EPA regarding the compliance of packaging claims on certain of our products in the air and water filtration categories and a limited subset of humidifier products within the Health & Wellness segment that are sold in the U.S. The EPA did not raise any product quality, safety or performance issues. As a result of these packaging compliance discussions, we voluntarily implemented a temporary stop shipment action on the impacted products as we worked with the EPA towards an expedient resolution. Our fiscal 2022 consolidated, and Health & Wellness segment’s, net sales revenue, gross profit and operating income was materially and adversely impacted by the stop shipment actions and the time needed to execute repackaging plans. While we have resumed normalized levels of shipping of the affected inventory, we are still in process of repackaging our existing inventory of impacted products. Additionally, as a result of continuing dialogue with the EPA, we are executing further repackaging and relabeling plans on certain additional humidifier products and certain additional air filtration products. If we are not able to execute our repackaging plans on schedule to meet demand, our net sales revenue, gross profit and operating income could continue to be materially and adversely impacted. Although, we are not aware of any fines or penalties related to this matter imposed against us by the EPA, there can be no assurances that such fines or penalties will not be imposed. We recorded charges to cost of goods sold to write-off obsolete packaging for the affected products in our inventory on-hand and in-transit. We have also incurred additional compliance costs comprised of obsolete packaging, storage and other charges from vendors, which were recognized in cost of goods sold and incremental warehouse storage costs and legal fees, which were recognized in SG&A. We refer to these charges as “EPA compliance costs.” A summary of EPA compliance costs incurred during the periods presented follows: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 Cost of goods sold $ 7,103 $ 357 $ 16,558 1 $ 13,469 2 SG&A 1,251 2,603 3,440 2,603 Total EPA compliance costs $ 8,354 $ 2,960 $ 19,998 $ 16,072 (1) Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023. (2) Includes a $13.1 million charge to cost of goods sold to write-off the obsolete packaging for the affected air filtration, water filtration and humidifier products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2022. In addition, we have incurred and capitalized into inventory costs to repackage a portion of our existing inventory of the affected products since the second quarter of fiscal 2022 and expect to continue to incur and capitalize such costs as we continue to repackage inventory. We also expect to incur additional compliance costs, which may include incremental warehouse storage costs, charges from vendors, and legal fees, among other things. Such potential incremental EPA compliance costs will be expensed as incurred and could materially and adversely impact our consolidated and Health & Wellness segment’s gross profit and operating income. In addition, our net sales revenue could be materially and adversely impacted by customer returns, an increase in sales discounts and allowances and by the potential impact of distribution losses at certain retailers. Additional impacts or more pronounced adverse impacts may arise that we are not currently aware of today. Accordingly, our business, results of operations and financial condition could be adversely and materially impacted in ways that we are not able to predict today. For additional information refer to Part I, Item 2., “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including “EPA Compliance Costs”.

Long-Term Debt

Long-Term Debt	6 Months Ended
	Aug. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	Note 10 - Long-Term Debt A summary of our long-term debt follows: (in thousands) August 31, 2022 February 28, 2022 Mississippi Business Finance Corporation Loan (the “MBFC Loan”) (1) $ 14,807 $ 16,707 Credit Agreement (1): Revolving loans 908,000 799,500 Term loans 250,000 — Total borrowings under Credit Agreement 1,158,000 799,500 Subtotal 1,172,807 816,207 Unamortized prepaid financing fees (3,065) (2,991) Total long-term debt 1,169,742 813,216 Less: current maturities of long-term debt (20,872) (1,884) Long-term debt, excluding current maturities $ 1,148,870 $ 811,332 (1) The weighted average interest rates on borrowings outstanding under both the MBFC Loan and Credit Agreement as of August 31, 2022 and February 28, 2022 were 3.9% and 1.2%, respectively. Aggregate annual maturities of our long-term debt as of August 31, 2022 are as follows: (in thousands) Fiscal 2023 (balance for remainder of fiscal year) $ 3,125 Fiscal 2024 21,057 Fiscal 2025 6,250 Fiscal 2026 1,142,375 Fiscal 2027 — Thereafter — Total $ 1,172,807 Capitalized Interest During the three and six month periods ended August 31, 2022, we incurred interest costs totaling $10.1 million and $15.2 million, respectively, of which we capitalized $0.9 million and $1.6 million, respectively, as part of property and equipment in connection with the construction of a new distribution center. During the three and six month periods ended August 31, 2021, we incurred interest costs totaling $3.3 million and $6.3 million, respectively, of which none was capitalized. Credit Agreement We have a credit agreement (the “Credit Agreement”) with Bank of America, N.A., as administrative agent, and other lenders that provides for an unsecured total revolving commitment of $1.25 billion and matures on March 13, 2025. At February 28, 2022, the Credit Agreement bore floating interest at either the Base Rate or the London Interbank Offered Rate (“LIBOR”), plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and LIBOR borrowings, respectively. On June 28, 2022, we entered into an amendment to the Credit Agreement to, among other things, replace LIBOR with Term SOFR (as defined in the Credit Agreement) as the reference interest rate. In connection with the amendment, we also (i) exercised the accordion under the Credit Agreement and borrowed $250 million as term loans, and (ii) provided a notice relating to a qualified acquisition, which triggered temporary adjustments to the maximum leverage ratio as further described below. The term loans will be payable at the end of each fiscal quarter in equal installments of 0.625% of the term loans made, beginning in the third quarter of fiscal 2023, with the remaining balance due at the maturity date. The maturity date of the term loans is March 13, 2025, which is the same maturity date as the revolving loans under the Credit Agreement. The proceeds from the term loans were used to repay revolving loans under the Credit Agreement. We may prepay the term loans, in whole or in part, at any time without premium or penalty. Following the amendment, borrowings under the Credit Agreement bear floating interest at either the Base Rate or Term SOFR, plus a margin based on the Net Leverage Ratio (as defined in the Credit Agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings. As a result of the notice for the qualified acquisition, the maximum leverage ratio is 4.00 to 1.00 through February 28, 2023, 3.75 to 1.00 through May 31, 2023 and 3.50 to 1.00 thereafter. As of August 31, 2022, the balance of outstanding letters of credit was $17.7 million and the amount available for revolving borrowings under our Credit Agreement was $324.3 million. Covenants in the Credit Agreement limit the amount of total indebtedness we can incur. As a result of our exercise of the qualified acquisition notice under the Credit Agreement, as of August 31, 2022, these covenants effectively limited our ability to incur more than $265.2 million of additional debt from all sources, including the Credit Agreement. The floating interest rates, on our borrowings under the Credit Agreement, are hedged with interest rate swaps to effectively fix interest rates on $125 million of the outstanding principal balance under the revolving loans as of both August 31, 2022 and February 28, 2022. In connection with amending our Credit Agreement, we updated our associated interest rate swap contracts to replace LIBOR with Term SOFR as the reference interest rate during the second quarter of fiscal 2023. In accordance with ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ( “ASU 2020-04”), we elected to apply the hedge accounting practical expedients related to changes to the critical terms of a hedging instrument, hedged item or forecasted transaction and changes in designated hedged interest rate risk. Application of these practical expedients allowed us to maintain hedge accounting for our interest rate swap contracts. See Notes 11, 12, and 13 for additional information regarding our interest rate swaps. Other Debt Agreements We have an unsecured loan agreement with the Mississippi Business Finance Corporation (the “MBFC”), which was entered into in connection with the issuance by MBFC of taxable industrial development revenue bonds. At February 28, 2022, the MBFC Loan bore floating interest based on either LIBOR plus a margin of up to 2.0%, or a Base Rate plus a margin of up to 1.0%, as determined by the interest rate elected and the Net Leverage Ratio defined in the loan agreement. On August 26, 2022, we entered into an amendment to the loan agreement for the unsecured MBFC Loan to, among other things, replace LIBOR with Term SOFR (as defined in the loan agreement) as the reference interest rate. Following the effective date of the amendment, borrowings under the MBFC Loan bear interest at either the Base Rate or Term SOFR (both as defined in the loan agreement), plus a margin based on the Net Leverage Ratio (as defined in the loan agreement) of 0% to 1.0% and 1.0% to 2.0% for Base Rate and Term SOFR borrowings, respectively, plus a credit spread of 0.10% for Term SOFR borrowings. In connection with amending the Credit Agreement and the MBFC Loan to replace LIBOR with Term SOFR (as defined in the respective agreements), we elected to apply the contract modification practical expedient in accordance with ASU 2020-04. Application of this practical expedient provided relief from the requirement to evaluate whether the modification resulted in an extinguishment and allowed us to account for the modification by prospectively adjusting the effective interest rate in the agreements. Debt Covenants As of August 31, 2022, we were in compliance with all covenants as defined under the terms of the Credit Agreement and our other debt agreements.

Fair Value

Fair Value	6 Months Ended
	Aug. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value	Note 11 - Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques under the accounting guidance related to fair value measurements are based on observable and unobservable inputs. These inputs are classified into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets; Level 2: Observable inputs other than quoted prices that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets; quoted prices for similar or identical assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable; and Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. Our financial assets and liabilities are classified as Level 2 because their valuation is dependent on observable inputs and other quoted prices for similar assets or liabilities, or model-derived valuations whose significant value drivers are observable. The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2 as follows: Carrying Amount and Fair Value (in thousands) August 31, 2022 February 28, 2022 Assets: Cash equivalents (money market accounts) $ 455 $ 438 Interest rate swaps 1,809 — Foreign currency derivatives 7,439 2,918 Total assets $ 9,703 $ 3,356 Liabilities: Interest rate swaps $ — $ 2,781 Foreign currency derivatives 193 825 Total liabilities $ 193 $ 3,606 The carrying amounts of cash, accounts payable, accrued expenses and other current liabilities and income taxes payable approximate fair value because of the short maturity of these items. The carrying amounts of receivables approximate fair value due to the effect of the related allowance for credit losses. The carrying amount of our floating rate long-term debt approximates its fair value. We use derivatives to manage our exposure to changes in foreign currency exchange rates, which include foreign currency forward contracts and cross-currency debt swaps. In addition, we use interest rate swaps to manage our exposure to changes in interest rates. All of our derivative assets and liabilities are recorded at fair value. See Notes 12 and 13 for more information on our derivatives.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
	Aug. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Note 12 - Financial Instruments and Risk Management Foreign Currency Risk The U.S. Dollar is the functional currency for the Company and all of its subsidiaries and is also the reporting currency for the Company. By operating internationally, we are subject to foreign currency risk from transactions denominated in currencies other than the U.S. Dollar (“foreign currencies”). Such transactions include sales, certain inventory purchases and operating expenses. As a result of such transactions, portions of our cash, trade accounts receivable and trade accounts payable are denominated in foreign currencies. Approximately 12% of our net sales revenue was denominated in foreign currencies during both the three and six month periods ended August 31, 2022, respectively, compared to 9% and 10%, respectively, for the same periods last year. These sales were primarily denominated in British Pounds, Euros, Mexican Pesos, Canadian Dollars and Norwegian Kroner. We make most of our inventory purchases from manufacturers in Asia and primarily use the U.S. Dollar for such purchases. In our condensed consolidated statements of income, foreign currency exchange rate gains and losses resulting from the remeasurement of foreign taxes receivable, taxes payable, deferred tax assets, and deferred tax liabilities are recognized in their respective income tax lines, and all other foreign currency exchange rate gains and losses are recognized in SG&A. During the three and six month periods ended August 31, 2022, we recorded foreign currency exchange rate net losses of $2.7 million and $2.5 million, respectively, in SG&A, compared to $0.9 million and $0.5 million, respectively, for the same periods last year. We mitigate certain foreign currency exchange rate risk by using forward contracts and cross-currency debt swaps to protect against the foreign currency exchange rate risk inherent in our transactions denominated in foreign currencies. We do not enter into any derivatives or similar instruments for trading or other speculative purposes. Certain of our forward contracts are designated as cash flow hedges (“foreign currency contracts”) and are recorded on the balance sheet at fair value with changes in fair value recorded in Other Comprehensive Income (Loss) (“OCI”) until the hedge transaction is settled, at which point amounts are reclassified from Accumulated Other Comprehensive Income (Loss) (“AOCI”) to our condensed consolidated statements of income. Foreign currency derivatives for which we have not elected hedge accounting consist of our forward contracts and cross-currency debt swaps, and any changes in the fair value of these derivatives are recorded in our condensed consolidated statements of income. These undesignated derivatives are used to hedge monetary net asset and liability positions. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. Interest Rate Risk Interest on our outstanding debt as of August 31, 2022 is based on floating interest rates. If short-term interest rates increase, we will incur higher interest expense on any future outstanding balances of floating rate debt. Floating interest rates are hedged with interest rate swaps to effectively fix interest rates on $125.0 million of the outstanding principal balance under the Credit Agreement, which totaled $1,158.0 million as of August 31, 2022. Our interest rate swaps are designated as cash flow hedges and are recorded on the balance sheet at fair value with changes in fair value recorded in OCI until the hedge transaction is settled, at which point amounts are reclassified from AOCI to our condensed consolidated statements of income. We evaluate our derivatives designated as cash flow hedges each quarter to assess hedge effectiveness. The following tables summarize the fair values of our derivative instruments as of the end of the periods presented: (in thousands) August 31, 2022 Derivatives designated as hedging instruments Hedge Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 6/2023 € 20,900 $ 2,489 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 11/2023 $ 39,050 1,204 149 — — Forward contracts - sell Pounds Cash flow 6/2023 £ 18,410 3,444 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 800 18 — — — Forward contracts - sell Norwegian Kroner Cash flow 6/2023 kr 36,180 135 — — — Interest rate swaps Cash flow 1/2024 $ 125,000 1,275 534 — — Subtotal 8,565 683 — — Derivatives not designated under hedge accounting Forward contracts - buy Euro (1) 9/2022 € 4,532 — — 74 — Forward contracts - buy Pounds (1) 9/2022 £ 2,291 — — 119 — Subtotal — — 193 — Total fair value $ 8,565 $ 683 $ 193 $ — (in thousands) February 28, 2022 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 2/2023 € 17,000 $ 1,224 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 2/2023 $ 40,000 475 — — — Forward contracts - sell Pounds Cash flow 2/2023 £ 24,000 1,219 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 5,700 — — 113 — Interest rate swaps Cash flow 1/2024 $ 125,000 — — 1,446 1,335 Subtotal 2,918 — 1,559 1,335 Derivatives not designated under hedge accounting Cross-currency debt swaps - Euro (2) 4/2022 € 6,000 — — 244 — Cross-currency debt swaps - Pounds (2) 4/2022 £ 4,500 — — 468 — Subtotal — — 712 — Total fair value $ 2,918 $ — $ 2,271 $ 1,335 (1) These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements. (2) These cross-currency debt swaps, for which we have not elected hedge accounting, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements. The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented: Three Months Ended August 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 6,226 $ 5,456 Sales revenue, net $ 2,715 $ (861) Interest rate swaps - cash flow hedges 1,423 66 Interest expense (281) (1,350) Total $ 7,649 $ 5,522 $ 2,434 $ (2,211) Six Months Ended August 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 8,545 $ 2,265 Sales revenue, net $ 3,911 $ (2,087) Interest rate swaps - cash flow hedges 3,629 (224) Interest expense (961) (2,634) Total $ 12,174 $ 2,041 $ 2,950 $ (4,721) The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented: Gain (Loss) Three Months Ended August 31, Six Months Ended August 31, (in thousands) Location 2022 2021 2022 2021 Forward contracts SG&A $ (250) $ — $ (250) $ — Cross-currency debt swaps - principal SG&A — 469 875 340 Cross-currency debt swaps - interest Interest expense — — — (2) Total $ (250) $ 469 $ 625 $ 338 We expect a net gain of $8.6 million associated with foreign currency contracts and interest rate swaps currently recorded in AOCI to be reclassified into income over the next twelve months. The amount ultimately realized, however, will differ as exchange rates and interest rates change and the underlying contracts settle. See Notes 11 and 13 to these condensed consolidated financial statements for more information. Counterparty Credit Risk Financial instruments, including foreign currency contracts, forward contracts, cross-currency debt swaps and interest rate swaps, expose us to counterparty credit risk for non-performance. We manage our exposure to counterparty credit risk by only dealing with counterparties who are substantial international financial institutions with significant experience using such derivative instruments. We believe that the risk of incurring credit losses is remote.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	6 Months Ended
	Aug. 31, 2022
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Accumulated Other Comprehensive Income (Loss)	Note 13 - Accumulated Other Comprehensive Income (Loss) The changes in AOCI by component and related tax effects for the periods presented were as follows: (in thousands) Interest Foreign Total Balance at February 28, 2021 $ (7,576) $ (4,080) $ (11,656) Other comprehensive (loss) income before reclassification (224) 2,265 2,041 Amounts reclassified out of AOCI 2,634 2,087 4,721 Tax effects (574) (743) (1,317) Other comprehensive income 1,836 3,609 5,445 Balance at August 31, 2021 $ (5,740) $ (471) $ (6,211) Balance at February 28, 2022 $ (2,126) $ 2,328 $ 202 Other comprehensive income before reclassification 3,629 8,545 12,174 Amounts reclassified out of AOCI 961 (3,911) (2,950) Tax effects (1,083) (1,143) (2,226) Other comprehensive income 3,507 3,491 6,998 Balance at August 31, 2022 $ 1,381 $ 5,819 $ 7,200 See Notes 10, 11 and 12 to these condensed consolidated financial statements for additional information regarding our cash flow hedges.

Segment Information

Segment Information	6 Months Ended
	Aug. 31, 2022
Segment Reporting [Abstract]
Segment Information	Note 14 - Segment Information The following tables summarize segment information for the periods presented: Three Months Ended August 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 240,559 $ 180,506 $ 100,335 $ 521,400 Restructuring charges 472 3,554 750 4,776 Operating income (loss) 42,082 (2,610) 7,474 46,946 Capital and intangible asset expenditures 32,420 2,810 1,203 36,433 Depreciation and amortization 4,493 3,021 3,605 11,119 Three Months Ended August 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 215,218 $ 141,479 $ 118,531 $ 475,228 Restructuring charges 369 — — 369 Operating income 41,921 4,794 20,576 67,291 Capital and intangible asset expenditures 17,050 2,232 666 19,948 Depreciation and amortization 2,815 2,624 3,289 8,728 Six Months Ended August 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 474,822 $ 349,447 $ 205,209 $ 1,029,478 Restructuring charges 472 3,554 752 4,778 Operating income (loss) 71,875 (8,752) 17,762 80,885 Capital and intangible asset expenditures 105,151 4,439 3,045 112,635 Depreciation and amortization 8,988 5,833 6,796 21,617 Six Months Ended August 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 408,862 $ 345,575 $ 262,014 $ 1,016,451 Restructuring charges 369 — 6 375 Operating income 69,064 16,043 47,019 132,126 Capital and intangible asset expenditures 20,037 2,980 937 23,954 Depreciation and amortization 5,363 5,350 6,728 17,441 The following table presents net sales revenue by geographic region, in U.S. Dollars: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 U.S. sales revenue, net $ 387,340 74.3 % $ 369,590 77.8 % $ 759,517 73.8 % $ 774,436 76.2 % International sales revenue, net 134,060 25.7 % 105,638 22.2 % 269,961 26.2 % 242,015 23.8 % Total sales revenue, net $ 521,400 100.0 % $ 475,228 100.0 % $ 1,029,478 100.0 % $ 1,016,451 100.0 %

Income Taxes

Income Taxes	6 Months Ended
	Aug. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 15 - Income Taxes We reorganized the Company in Bermuda in 1994 and many of our foreign subsidiaries are not directly or indirectly owned by a U.S. parent. As such, a large portion of our foreign income is not subject to U.S. taxation on a permanent basis under current law. Additionally, our intellectual property is largely owned by foreign subsidiaries, resulting in proportionally higher earnings in jurisdictions with lower statutory tax rates, which decreases our overall effective tax rate. The taxable income earned in each jurisdiction, whether U.S. or foreign, is determined by the subsidiary's operating results and transfer pricing and tax regulations in the related jurisdictions. For interim periods, our income tax expense and resulting effective tax rate are based upon an estimated annual effective tax rate adjusted for the effects of items required to be treated as discrete to the period, including changes in tax laws, changes in estimated exposures for uncertain tax positions and other items. On August 16, 2022, the Inflation Reduction Act (the “Act”) was enacted and signed into law in the United States. The Act is a budget reconciliation package that includes significant law changes relating to tax, climate change, energy, and health care. The tax provisions include, among other items, a corporate alternative minimum tax of 15%, an excise tax of 1% on corporate stock buy-backs, energy-related tax credits, and additional IRS funding. We do not expect the tax provisions of the Act to have a material impact to our consolidated financial statements. For the three months ended August 31, 2022, income tax expense as a percentage of income before income tax was 19.1% compared to 19.8% for the same period last year. The year-over-year decrease in the effective tax rate is primarily due to the mix of taxable income in our various tax jurisdictions. For the six months ended August 31, 2022, income tax expense as a percentage of income before income tax was 18.2% compared to 14.0% for the same period last year. The year-over-year increase in the effective tax rate is primarily due to lower forecasted annual income before income taxes, shifts in the mix of income in our various tax jurisdictions, and an increase in tax expense for discrete items.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Aug. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Note 16 - Earnings Per Share We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period. We compute diluted earnings per share using the weighted average number of shares of common stock outstanding plus the effect of dilutive securities. Dilutive securities at any given point in time may consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted stock units, performance stock units, restricted stock awards and performance restricted stock awards and other stock-based awards. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. See Note 6 to these condensed consolidated financial statements for more information regarding stock-based awards. The following table presents our weighted average basic and diluted shares outstanding for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 Weighted average shares outstanding, basic 23,969 24,101 23,917 24,225 Incremental shares from share-based compensation arrangements 87 246 172 267 Weighted average shares outstanding, diluted 24,056 24,347 24,089 24,492 Anti-dilutive securities 54 29 42 15

Basis of Presentation and Rel_2

Basis of Presentation and Related Information (Policies)	6 Months Ended
	Aug. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements are prepared in accordance with GAAP and include all of our subsidiaries. Our condensed consolidated financial statements are prepared in U.S. Dollars. All intercompany balances and transactions are eliminated in consolidation. The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results may differ materially from those estimates.

Assets and Liabilities Held f_2

Assets and Liabilities Held for Sale (Tables)	6 Months Ended
	Aug. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Carrying amounts of major asset classes for Personal Care classified as held-for-sale	The carrying amounts of the major classes of assets and liabilities for our Personal Care business that were classified as held for sale were as follows: (in thousands) February 28, 2022 Receivables, net of allowance of $23 $ 1,265 Inventory 611 Property and equipment, net of accumulated depreciation of $152 66 Assets held for sale $ 1,942 Accrued sales discounts and allowances $ 235 Liabilities held for sale $ 235

Acquisitions (Tables)

Acquisitions (Tables)	6 Months Ended
	Aug. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of business acquisitions, by acquisition	The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 4,211 Inventory 7,890 Prepaid expenses and other current assets 119 Property and equipment 212 Goodwill 118,613 Trade names - definite 21,000 Customer relationships - definite 12,000 Deferred tax assets, net 360 Total assets 164,405 Liabilities: Accounts payable 1,401 Accrued expenses and other current liabilities 2,583 Income taxes payable 2,538 Deferred tax liabilities, net 8,187 Total liabilities 14,709 Net assets recorded $ 149,696 The following table presents the preliminary estimated fair values of assets acquired and liabilities assumed at the acquisition date: (in thousands) Assets: Receivables $ 11,758 Inventory 30,056 Prepaid expenses and other current assets 3,699 Income taxes receivable 4,169 Property and equipment 11,386 Goodwill 206,699 Trade names - indefinite 170,000 Customer relationships - definite 22,000 Operating lease assets 2,155 Total assets 461,922 Liabilities: Accounts payable 3,780 Accrued expenses and other current liabilities 7,334 Lease liabilities, non-current 1,719 Deferred tax liabilities, net 39,794 Total liabilities 52,627 Net assets recorded $ 409,295
Business acquisition, pro forma information	The impact of the acquisition of Curlsmith on our condensed consolidated statements of income for the periods presented was as follows: (in thousands, except earnings per share data) Three Months Ended Six Months Ended Sales revenue, net $ 10,207 $ 13,453 Net income 1,437 1,876 EPS: Basic $ 0.06 $ 0.08 Diluted $ 0.06 $ 0.08 (1) Represents approximately nineteen weeks of operating results from Curlsmith, acquired on April 22, 2022. The following supplemental unaudited pro forma information presents our financial results as if the acquisition of Curlsmith had occurred on March 1, 2021. This supplemental pro forma information has been prepared for comparative purposes and would not necessarily indicate what may have occurred if the acquisition had been completed on March 1, 2021, and this information is not intended to be indicative of future results. Three Months Ended Six Months Ended (in thousands, except earnings per share data) 2022 2021 2022 2021 Sales revenue, net $ 521,400 $ 483,586 $ 1,036,570 $ 1,034,443 Net income 30,672 52,156 57,180 107,260 EPS: Basic $ 1.28 $ 2.16 $ 2.39 $ 4.43 Diluted $ 1.28 $ 2.14 $ 2.37 $ 4.38

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Aug. 31, 2022
Payables and Accruals [Abstract]
Schedule of accrued expenses and other current liabilities	A summary of accrued expenses and other current liabilities was as follows: (in thousands) August 31, 2022 February 28, 2022 Accrued compensation, benefits and payroll taxes $ 20,643 $ 55,405 Accrued sales discounts and allowances 72,380 69,120 Accrued sales returns 29,639 33,384 Accrued advertising 54,591 55,775 Other 57,880 57,991 Total accrued expenses and other current liabilities $ 235,133 $ 271,675

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	6 Months Ended
	Aug. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense in SG&A	We recorded share-based compensation expense in SG&A as follows: Three Months Ended August 31, Six Months Ended (in thousands) 2022 2021 2022 2021 Directors stock compensation $ 222 $ 163 $ 395 $ 323 Service Condition Awards 2,160 3,296 5,277 5,236 Performance Condition Awards 3,196 3,061 14,041 13,084 Market Condition Awards 1,917 1,260 3,827 2,389 Employee stock purchase plan — — 574 768 Share-based compensation expense 7,495 7,780 24,114 21,800 Less income tax benefits (570) (712) (1,654) (1,571) Share-based compensation expense, net of income tax benefits $ 6,925 $ 7,068 $ 22,460 $ 20,229

Repurchases of Common Stock (Ta

Repurchases of Common Stock (Tables)	6 Months Ended
	Aug. 31, 2022
Equity [Abstract]
Summary of share repurchase activity	The following table summarizes our share repurchase activity for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands, except share and per share data) 2022 2021 2022 2021 Common stock repurchased on the open market: Number of shares — — — 436,842 Aggregate value of shares $ — $ — $ — $ 95,484 Average price per share $ — $ — $ — $ 218.58 Common stock received in connection with share-based compensation: Number of shares 501 503 89,959 66,147 Aggregate value of shares $ 81 $ 116 $ 18,305 $ 14,706 Average price per share $ 163.28 $ 229.76 $ 203.49 $ 222.32

Restructuring Plan (Tables)

Restructuring Plan (Tables)	6 Months Ended
	Aug. 31, 2022
Restructuring and Related Activities [Abstract]
Summary of restructuring charges recorded	The following tables summarize restructuring charges recorded as a result of Project Pegasus for the periods presented: Three Months Ended August 31, 2022 (in thousands) Home & Health & Beauty Total Severance and employee related costs $ 472 $ 1,926 $ 443 $ 2,841 Professional fees — 128 — 128 Contract termination — 1,500 — 1,500 Other — — 307 307 Total restructuring charges $ 472 $ 3,554 $ 750 $ 4,776 Six Months Ended August 31, 2022 Total (in thousands) Home & Health & Beauty Total Severance and employee related costs $ 472 $ 1,926 $ 445 $ 2,843 $ 2,843 Professional fees — 128 — 128 128 Contract termination — 1,500 — 1,500 1,500 Other — — 307 307 307 Total restructuring charges $ 472 $ 3,554 $ 752 $ 4,778 $ 4,778
Rollforward of restructuring reserve	The table below presents a rollforward of our accruals related to Project Pegasus, which are included in accrued expenses and other current liabilities: (in thousands) Balance at February 28, 2022 Charges Payments Balance at August 31, 2022 Severance and employee related costs $ — $ 2,843 $ 802 $ 2,041 Professional fees — 128 128 — Contract termination — 1,500 — 1,500 Other — 307 307 — Total $ — $ 4,778 $ 1,237 $ 3,541

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	6 Months Ended
	Aug. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Production Related Impairments	We refer to these charges as “EPA compliance costs.” A summary of EPA compliance costs incurred during the periods presented follows: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 Cost of goods sold $ 7,103 $ 357 $ 16,558 1 $ 13,469 2 SG&A 1,251 2,603 3,440 2,603 Total EPA compliance costs $ 8,354 $ 2,960 $ 19,998 $ 16,072 (1) Includes a $4.4 million charge to write-off the obsolete packaging for the affected additional humidifier products and affected additional air filtration products in our inventory on-hand and in-transit as of the end of the first quarter of fiscal 2023.

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Aug. 31, 2022
Debt Disclosure [Abstract]
Summary of long-term debt	A summary of our long-term debt follows: (in thousands) August 31, 2022 February 28, 2022 Mississippi Business Finance Corporation Loan (the “MBFC Loan”) (1) $ 14,807 $ 16,707 Credit Agreement (1): Revolving loans 908,000 799,500 Term loans 250,000 — Total borrowings under Credit Agreement 1,158,000 799,500 Subtotal 1,172,807 816,207 Unamortized prepaid financing fees (3,065) (2,991) Total long-term debt 1,169,742 813,216 Less: current maturities of long-term debt (20,872) (1,884) Long-term debt, excluding current maturities $ 1,148,870 $ 811,332 (1) The weighted average interest rates on borrowings outstanding under both the MBFC Loan and Credit Agreement as of August 31, 2022 and February 28, 2022 were
Schedule of Maturities of Long-Term Debt	Aggregate annual maturities of our long-term debt as of August 31, 2022 are as follows: (in thousands) Fiscal 2023 (balance for remainder of fiscal year) $ 3,125 Fiscal 2024 21,057 Fiscal 2025 6,250 Fiscal 2026 1,142,375 Fiscal 2027 — Thereafter — Total $ 1,172,807

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Aug. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of carrying value and fair value of financial assets and liabilities recorded at fair value and measured on a recurring basis and classified as level 2	The following table presents the carrying amount and fair value of our financial assets and liabilities measured and recorded at fair value on a recurring basis and classified as Level 2 as follows: Carrying Amount and Fair Value (in thousands) August 31, 2022 February 28, 2022 Assets: Cash equivalents (money market accounts) $ 455 $ 438 Interest rate swaps 1,809 — Foreign currency derivatives 7,439 2,918 Total assets $ 9,703 $ 3,356 Liabilities: Interest rate swaps $ — $ 2,781 Foreign currency derivatives 193 825 Total liabilities $ 193 $ 3,606

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	6 Months Ended
	Aug. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair values of derivative instruments	The following tables summarize the fair values of our derivative instruments as of the end of the periods presented: (in thousands) August 31, 2022 Derivatives designated as hedging instruments Hedge Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 6/2023 € 20,900 $ 2,489 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 11/2023 $ 39,050 1,204 149 — — Forward contracts - sell Pounds Cash flow 6/2023 £ 18,410 3,444 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 800 18 — — — Forward contracts - sell Norwegian Kroner Cash flow 6/2023 kr 36,180 135 — — — Interest rate swaps Cash flow 1/2024 $ 125,000 1,275 534 — — Subtotal 8,565 683 — — Derivatives not designated under hedge accounting Forward contracts - buy Euro (1) 9/2022 € 4,532 — — 74 — Forward contracts - buy Pounds (1) 9/2022 £ 2,291 — — 119 — Subtotal — — 193 — Total fair value $ 8,565 $ 683 $ 193 $ — (in thousands) February 28, 2022 Derivatives designated as hedging instruments Hedge Type Final Notional Amount Prepaid Other Assets Accrued Other Forward contracts - sell Euro Cash flow 2/2023 € 17,000 $ 1,224 $ — $ — $ — Forward contracts - sell Canadian Dollars Cash flow 2/2023 $ 40,000 475 — — — Forward contracts - sell Pounds Cash flow 2/2023 £ 24,000 1,219 — — — Forward contracts - sell Australian Dollars Cash flow 12/2022 A$ 5,700 — — 113 — Interest rate swaps Cash flow 1/2024 $ 125,000 — — 1,446 1,335 Subtotal 2,918 — 1,559 1,335 Derivatives not designated under hedge accounting Cross-currency debt swaps - Euro (2) 4/2022 € 6,000 — — 244 — Cross-currency debt swaps - Pounds (2) 4/2022 £ 4,500 — — 468 — Subtotal — — 712 — Total fair value $ 2,918 $ — $ 2,271 $ 1,335 (1) These forward contracts, for which we have not elected hedge accounting, hedge monetary net asset and liability positions for the notional amounts reported, creating an economic hedge against currency movements. (2) These cross-currency debt swaps, for which we have not elected hedge accounting, adjust the currency denomination of a portion of our outstanding debt to the Euro and British Pound, as applicable, for the notional amounts reported, creating an economic hedge against currency movements.
Schedule of pre-tax effect of derivative instruments designated as hedges	The pre-tax effects of derivative instruments designated as cash flow hedges were as follows for the periods presented: Three Months Ended August 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 6,226 $ 5,456 Sales revenue, net $ 2,715 $ (861) Interest rate swaps - cash flow hedges 1,423 66 Interest expense (281) (1,350) Total $ 7,649 $ 5,522 $ 2,434 $ (2,211) Six Months Ended August 31, Gain (Loss) Gain (Loss) Reclassified (in thousands) 2022 2021 Location 2022 2021 Foreign currency contracts - cash flow hedges $ 8,545 $ 2,265 Sales revenue, net $ 3,911 $ (2,087) Interest rate swaps - cash flow hedges 3,629 (224) Interest expense (961) (2,634) Total $ 12,174 $ 2,041 $ 2,950 $ (4,721)
Schedule of pre-tax effect of derivative instruments not designated as hedges	The pre-tax effects of derivative instruments not designated under hedge accounting were as follows for the periods presented: Gain (Loss) Three Months Ended August 31, Six Months Ended August 31, (in thousands) Location 2022 2021 2022 2021 Forward contracts SG&A $ (250) $ — $ (250) $ — Cross-currency debt swaps - principal SG&A — 469 875 340 Cross-currency debt swaps - interest Interest expense — — — (2) Total $ (250) $ 469 $ 625 $ 338

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	6 Months Ended
	Aug. 31, 2022
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Summary of changes in accumulated other comprehensive income (loss)	The changes in AOCI by component and related tax effects for the periods presented were as follows: (in thousands) Interest Foreign Total Balance at February 28, 2021 $ (7,576) $ (4,080) $ (11,656) Other comprehensive (loss) income before reclassification (224) 2,265 2,041 Amounts reclassified out of AOCI 2,634 2,087 4,721 Tax effects (574) (743) (1,317) Other comprehensive income 1,836 3,609 5,445 Balance at August 31, 2021 $ (5,740) $ (471) $ (6,211) Balance at February 28, 2022 $ (2,126) $ 2,328 $ 202 Other comprehensive income before reclassification 3,629 8,545 12,174 Amounts reclassified out of AOCI 961 (3,911) (2,950) Tax effects (1,083) (1,143) (2,226) Other comprehensive income 3,507 3,491 6,998 Balance at August 31, 2022 $ 1,381 $ 5,819 $ 7,200

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Aug. 31, 2022
Segment Reporting [Abstract]
Schedule of segment information	The following tables summarize segment information for the periods presented: Three Months Ended August 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 240,559 $ 180,506 $ 100,335 $ 521,400 Restructuring charges 472 3,554 750 4,776 Operating income (loss) 42,082 (2,610) 7,474 46,946 Capital and intangible asset expenditures 32,420 2,810 1,203 36,433 Depreciation and amortization 4,493 3,021 3,605 11,119 Three Months Ended August 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 215,218 $ 141,479 $ 118,531 $ 475,228 Restructuring charges 369 — — 369 Operating income 41,921 4,794 20,576 67,291 Capital and intangible asset expenditures 17,050 2,232 666 19,948 Depreciation and amortization 2,815 2,624 3,289 8,728 Six Months Ended August 31, 2022 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 474,822 $ 349,447 $ 205,209 $ 1,029,478 Restructuring charges 472 3,554 752 4,778 Operating income (loss) 71,875 (8,752) 17,762 80,885 Capital and intangible asset expenditures 105,151 4,439 3,045 112,635 Depreciation and amortization 8,988 5,833 6,796 21,617 Six Months Ended August 31, 2021 (in thousands) Home & Outdoor Health & Wellness Beauty Total Sales revenue, net $ 408,862 $ 345,575 $ 262,014 $ 1,016,451 Restructuring charges 369 — 6 375 Operating income 69,064 16,043 47,019 132,126 Capital and intangible asset expenditures 20,037 2,980 937 23,954 Depreciation and amortization 5,363 5,350 6,728 17,441 The following table presents net sales revenue by geographic region, in U.S. Dollars: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 U.S. sales revenue, net $ 387,340 74.3 % $ 369,590 77.8 % $ 759,517 73.8 % $ 774,436 76.2 % International sales revenue, net 134,060 25.7 % 105,638 22.2 % 269,961 26.2 % 242,015 23.8 % Total sales revenue, net $ 521,400 100.0 % $ 475,228 100.0 % $ 1,029,478 100.0 % $ 1,016,451 100.0 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Aug. 31, 2022
Earnings Per Share [Abstract]
Schedule of components of basic and diluted shares	The following table presents our weighted average basic and diluted shares outstanding for the periods shown: Three Months Ended August 31, Six Months Ended August 31, (in thousands) 2022 2021 2022 2021 Weighted average shares outstanding, basic 23,969 24,101 23,917 24,225 Incremental shares from share-based compensation arrangements 87 246 172 267 Weighted average shares outstanding, diluted 24,056 24,347 24,089 24,492 Anti-dilutive securities 54 29 42 15

Basis of Presentation and Rel_3

Basis of Presentation and Related Information (Details) $ / shares in Units, $ in Thousands					6 Months Ended
	Apr. 22, 2022 USD ($)	Mar. 25, 2022 USD ($)	Dec. 29, 2021 USD ($)	Jun. 07, 2021 USD ($)	Aug. 31, 2022 USD ($) segment $ / shares	Aug. 31, 2021 USD ($)	Feb. 28, 2022 $ / shares
Discontinued Operations
Common shares, par value (in dollars per share) | $ / shares					$ 0.10		$ 0.10
Number of segments | segment					3
Proceeds from sale of personal care business				$ 44,700	$ 1,804	$ 44,700
Gain on sale of North America Personal Care business				$ (500)	1,336	513
Net payments to acquire businesses, net of cash acquired					$ 148,111	$ 0
Curlsmith
Discontinued Operations
Net payments to acquire businesses, net of cash acquired	$ 149,700
Osprey Packs, Inc.
Discontinued Operations
Net payments to acquire businesses, net of cash acquired			$ 409,300
Latin America and Caribbean Personal Care Business
Discontinued Operations
Proceeds from sale of personal care business		$ 1,800
Gain on sale of North America Personal Care business		$ (1,300)

Assets and Liabilities Held f_3

Assets and Liabilities Held for Sale - Narrative (Details) - USD ($) $ in Thousands			6 Months Ended
	Mar. 25, 2022	Jun. 07, 2021	Aug. 31, 2022	Aug. 31, 2021
Long Lived Assets Held-for-sale [Line Items]
Proceeds from sale of personal care business		$ 44,700	$ 1,804	$ 44,700
Gain on sale of North America Personal Care business		$ (500)	$ 1,336	$ 513
Latin America and Caribbean Personal Care Business
Long Lived Assets Held-for-sale [Line Items]
Proceeds from sale of personal care business	$ 1,800
Gain on sale of North America Personal Care business	$ (1,300)

Assets and Liabilities Held f_4

Assets and Liabilities Held for Sale - Carrying Amounts of Assets Held for Sale (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale	$ 0	$ 1,942
Liabilities held for sale	0	235
Allowance on receivables	1,718	843
Property and equipment, accumulated depreciation	$ 173,614	161,006
Personal Care
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale		1,942
Liabilities held for sale		235
Allowance on receivables		23
Personal Care | Accrued sales discounts and allowances
Long Lived Assets Held-for-sale [Line Items]
Liabilities held for sale		235
Accounts receivable | Personal Care
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale		1,265
Inventory | Personal Care
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale		611
Property, plant and equipment | Personal Care
Long Lived Assets Held-for-sale [Line Items]
Assets held for sale		66
Property, Plant and Equipment, Held-for-Sale | Personal Care
Long Lived Assets Held-for-sale [Line Items]
Property and equipment, accumulated depreciation		$ 152

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended	6 Months Ended
	Apr. 22, 2022	Dec. 29, 2021	Aug. 31, 2022	Aug. 31, 2022	Aug. 31, 2021
Business Acquisition [Line Items]
Net payments to acquire businesses				$ 148,111	$ 0
Customer Relationships
Business Acquisition [Line Items]
Trade names and customer relationships - definite		$ 22,000
Curlsmith
Business Acquisition [Line Items]
Net payments to acquire businesses	$ 149,700
Net working capital adjustment	$ 300
Acquisition related expenses				2,700
Reduction to goodwill			$ (100)
Curlsmith | Trade Names
Business Acquisition [Line Items]
Expected life	20 years
Up-front license fee	$ 21,000
Trade names and customer relationships - definite	$ 21,000
Curlsmith | Customer Relationships
Business Acquisition [Line Items]
Expected life	19 years 6 months
Up-front license fee	$ 12,000
Trade names and customer relationships - definite	$ 12,000
Osprey Packs, Inc.
Business Acquisition [Line Items]
Net payments to acquire businesses		$ 409,300
Acquisition related expenses				100
Expected life		4 years 6 months
Net working capital adjustment		$ 10,700
Reduction to total purchase consideration				1,600
Reduction to accounts payable acquired				700
Reduction to goodwill				$ 2,300
Osprey Packs, Inc. | Trade Names
Business Acquisition [Line Items]
Trade names - indefinite		170,000
Osprey Packs, Inc. | Customer Relationships
Business Acquisition [Line Items]
Trade names and customer relationships - definite		$ 22,000

Acquisitions - Business Acquisi

Acquisitions - Business Acquisitions, by Acquisition (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Apr. 22, 2022	Feb. 28, 2022	Dec. 29, 2021
Assets
Goodwill	$ 1,065,214		$ 948,873
Liabilities:
Income taxes payable		$ 2,538
Customer Relationships
Assets
Trade names and customer relationships - definite				$ 22,000
Curlsmith
Assets
Receivables		4,211
Inventory		7,890
Prepaid expenses and other current assets		119
Property and equipment		212
Goodwill		118,613
Deferred tax assets, net		360
Total assets		164,405
Liabilities:
Accounts payable		1,401
Accrued expenses and other current liabilities		2,583
Deferred tax liabilities, net		8,187
Total liabilities		14,709
Net assets recorded		149,696
Curlsmith | Trade Names
Assets
Trade names and customer relationships - definite		21,000
Curlsmith | Customer Relationships
Assets
Trade names and customer relationships - definite		$ 12,000
Osprey Packs, Inc.
Assets
Receivables				11,758
Inventory				30,056
Prepaid expenses and other current assets				3,699
Income taxes receivable				4,169
Property and equipment				11,386
Goodwill				206,699
Operating lease assets				2,155
Total assets				461,922
Liabilities:
Accounts payable				3,780
Accrued expenses and other current liabilities				7,334
Lease liabilities, non-current				1,719
Deferred tax liabilities, net				39,794
Total liabilities				52,627
Net assets recorded				409,295
Osprey Packs, Inc. | Trade Names
Assets
Trade names - indefinite				170,000
Osprey Packs, Inc. | Customer Relationships
Assets
Trade names and customer relationships - definite				$ 22,000

Acquisitions - Impact of the Ac

Acquisitions - Impact of the Acquisition of Curlsmith on Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	6 Months Ended
	Aug. 31, 2022	Aug. 31, 2022	Apr. 22, 2022	Feb. 28, 2022	Dec. 29, 2021
EPS:
Goodwill	$ 1,065,214	$ 1,065,214		$ 948,873
Customer Relationships
EPS:
Trade names and customer relationships - definite					$ 22,000
Curlsmith
Business Acquisition [Line Items]
Sales revenue, net	10,207	13,453
Net income	$ 1,437	$ 1,876
EPS:
Basic (in dollars per share)	$ 0.06	$ 0.08
Diluted (in dollars per share)	$ 0.06	$ 0.08
Receivables			$ 4,211
Inventory			7,890
Prepaid expenses and other current assets			119
Property and equipment			212
Goodwill			118,613
Total assets			164,405
Accounts payable			1,401
Accrued expenses and other current liabilities			2,583
Deferred tax liabilities, net			8,187
Total liabilities			14,709
Net assets recorded			149,696
Curlsmith | Trade Names
EPS:
Trade names and customer relationships - definite			21,000
Curlsmith | Customer Relationships
EPS:
Trade names and customer relationships - definite			$ 12,000
Osprey Packs, Inc.
EPS:
Receivables					11,758
Inventory					30,056
Prepaid expenses and other current assets					3,699
Income taxes receivable					4,169
Property and equipment					11,386
Goodwill					206,699
Operating lease assets					2,155
Total assets					461,922
Accounts payable					3,780
Accrued expenses and other current liabilities					7,334
Lease liabilities, non-current					1,719
Deferred tax liabilities, net					39,794
Total liabilities					52,627
Net assets recorded					409,295
Osprey Packs, Inc. | Trade Names
EPS:
Trade names - indefinite					170,000
Osprey Packs, Inc. | Customer Relationships
EPS:
Trade names and customer relationships - definite					$ 22,000

Acquisitions - Pro Forma Inform

Acquisitions - Pro Forma Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
EPS:
Weeks of operating results included in results			133 days
Curlsmith
Business Acquisition [Line Items]
Sales revenue, net	$ 521,400	$ 483,586	$ 1,036,570	$ 1,034,443
Net income	$ 30,672	$ 52,156	$ 57,180	$ 107,260
EPS:
Basic (in dollars per share)	$ 1.28	$ 2.16	$ 2.39	$ 4.43
Diluted (in dollars per share)	$ 1.28	$ 2.14	$ 2.37	$ 4.38

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Payables and Accruals [Abstract]
Accrued compensation, benefits and payroll taxes	$ 20,643	$ 55,405
Accrued sales discounts and allowances	72,380	69,120
Accrued sales returns	29,639	33,384
Accrued advertising	54,591	55,775
Other	57,880	57,991
Accrued expenses and other current liabilities	$ 235,133	$ 271,675

Share-Based Compensation Plan_2

Share-Based Compensation Plans - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	6 Months Ended
	May 31, 2022	Aug. 31, 2022
Share-based compensation plans
Expected recognition period for unrecognized share-based compensation		2 years 1 month 6 days
Target achievement for Performance Condition Awards, as a percentage		150%
Restricted Stock
Share-based compensation plans
Number of awards granted (in shares)	165,734
Unrecognized share-based compensation		$ 50.8
Service Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	36,088
Grant date fair value of shares granted in period (in dollars per share)	$ 204.11
Market Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	82,867
Grant date fair value of shares granted in period (in dollars per share)	$ 152.91
Performance Condition Awards
Share-based compensation plans
Number of awards granted (in shares)	82,867
Grant date fair value of shares granted in period (in dollars per share)	$ 204.11

Share-Based Compensation Plan_3

Share-Based Compensation Plans - Share-Based Compensation Expense in SG&A (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense, net of income tax benefits	$ 6,925	$ 7,068	$ 22,460	$ 20,229
SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	7,495	7,780	24,114	21,800
Less income tax benefits	(570)	(712)	(1,654)	(1,571)
Service Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	2,160	3,296	5,277	5,236
Performance Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	3,196	3,061	14,041	13,084
Market Condition Awards | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	1,917	1,260	3,827	2,389
Employee stock purchase plan | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	0	0	574	768
Directors stock compensation | SG&A
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 222	$ 163	$ 395	$ 323

Repurchases of Common Stock - N

Repurchases of Common Stock - Narrative (Details) - USD ($)	1 Months Ended
	Aug. 31, 2021	Aug. 31, 2022
Equity [Abstract]
Amount of shares authorized for purchase	$ 500,000,000
Period for stock repurchase	3 years
Remaining share repurchase amount		$ 403,700,000

Repurchases of Common Stock - S

Repurchases of Common Stock - Summary of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2022	May 31, 2022	Aug. 31, 2021	May 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Repurchase of common stock
Aggregate value of shares	$ 81	$ 18,224	$ 116	$ 110,074
Stock Compensation Plan
Repurchase of common stock
Number of shares (in shares)	501		503		89,959	66,147
Aggregate value of shares	$ 81		$ 116		$ 18,305	$ 14,706
Average price per share (in dollars per share)	$ 163.28		$ 229.76		$ 203.49	$ 222.32
Open Market
Repurchase of common stock
Number of shares (in shares)	0		0		0	436,842
Aggregate value of shares	$ 0		$ 0		$ 0	$ 95,484
Average price per share (in dollars per share)	$ 0		$ 0		$ 0	$ 218.58

Restructuring Plan - Narrative

Restructuring Plan - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Restructuring Plan
Restructuring charges	$ 4,776	$ 369	$ 4,778	$ 375
Minimum
Restructuring Plan
Expected restructuring costs	85,000		85,000
Maximum
Restructuring Plan
Expected restructuring costs	$ 95,000		95,000
Project Pegasus
Restructuring Plan
Estimated percentage reduction in cost of good sold	60%
Estimated percentage reduction in SG&A expenses	40%
Restructuring charges	$ 4,776		$ 4,778
Project Pegasus | Fiscal 2024
Restructuring Plan
Estimated percentage of savings recognized			25%
Project Pegasus | Fiscal 2025
Restructuring Plan
Estimated percentage of savings recognized			50%
Project Pegasus | Fiscal 2026
Restructuring Plan
Estimated percentage of savings recognized			25%
Project Pegasus | Minimum
Restructuring Plan
Annualized profit improvements	75,000
Project Pegasus | Maximum
Restructuring Plan
Annualized profit improvements	$ 85,000
Project Refuel
Restructuring Plan
Restructuring charges		$ 400		$ 400

Restructuring Plan - Restructur

Restructuring Plan - Restructuring Charges to Date (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Restructuring Plan
Restructuring charges	$ 4,776	$ 369	$ 4,778	$ 375
Project Pegasus
Restructuring Plan
Severance and employee related costs	2,841		2,843
Professional fees	128		128
Contract termination	1,500		1,500
Other	307		307
Restructuring charges	4,776		4,778
Home & Outdoor | Project Pegasus
Restructuring Plan
Severance and employee related costs	472		472
Professional fees	0		0
Contract termination	0		0
Other	0		0
Restructuring charges	472		472
Health & Wellness
Restructuring Plan
Restructuring charges	3,554	0	3,554	0
Health & Wellness | Project Pegasus
Restructuring Plan
Severance and employee related costs	1,926		1,926
Professional fees	128		128
Contract termination	1,500		1,500
Other	0		0
Restructuring charges	3,554		3,554
Beauty
Restructuring Plan
Restructuring charges	750	$ 0	752	$ 6
Beauty | Project Pegasus
Restructuring Plan
Severance and employee related costs	443		445
Professional fees	0		0
Contract termination	0		0
Other	307		307
Restructuring charges	$ 750		$ 752

Restructuring Plan - Reserve Ro

Restructuring Plan - Reserve Roll Forward (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Restructuring Reserve [Roll Forward]
Charges	$ 4,776	$ 369	$ 4,778	$ 375
Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			0
Charges	4,776		4,778
Payments			1,237
Restructuring liability, ending balance	3,541		3,541
Employee Severance | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			0
Charges			2,843
Payments			802
Restructuring liability, ending balance	2,041		2,041
Professional Fees | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			0
Charges			128
Payments			128
Restructuring liability, ending balance	0		0
Contract Termination | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			0
Charges			1,500
Payments			0
Restructuring liability, ending balance	1,500		1,500
Other Restructuring | Project Pegasus
Restructuring Reserve [Roll Forward]
Restructuring liability, beginning balance			0
Charges			307
Payments			307
Restructuring liability, ending balance	$ 0		$ 0

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Thousands		3 Months Ended		6 Months Ended
	Mar. 30, 2022 USD ($)	Aug. 31, 2022 USD ($)	Aug. 31, 2021 USD ($)	Aug. 31, 2022 USD ($)	Aug. 31, 2021 USD ($)	Dec. 23, 2021 renewal
Commitments and contingencies
Number of other companies named in litigation | renewal						5
Weather-Related Incident
Commitments and contingencies
Weather related inventory write-down	$ 34,400
Probable insurance recoveries	34,400
Health & Wellness
Commitments and contingencies
Charge to write off obsolete packaging		$ 8,354	$ 2,960	$ 19,998	$ 16,072
Health & Wellness | Weather-Related Incident
Commitments and contingencies
Weather related inventory write-down	29,900
Health & Wellness | Cost of Sales
Commitments and contingencies
Charge to write off obsolete packaging		7,103	357	16,558	13,469
Health & Wellness | Cost of Sales | Obsolete Packaging
Commitments and contingencies
Charge to write off obsolete packaging				4,400	13,100
Health & Wellness | SG&A
Commitments and contingencies
Charge to write off obsolete packaging		$ 1,251	$ 2,603	$ 3,440	$ 2,603
Beauty | Weather-Related Incident
Commitments and contingencies
Weather related inventory write-down	$ 4,500

Long-Term Debt - Schedule (Deta

Long-Term Debt - Schedule (Details) - USD ($) $ in Thousands				12 Months Ended
	Aug. 24, 2022	Jun. 28, 2022	Feb. 28, 2022	Feb. 28, 2022	Aug. 31, 2022
Long-term debt
Aggregate principal balance			$ 816,207	$ 816,207	$ 1,172,807
Unamortized prepaid financing fees			(2,991)	(2,991)	(3,065)
Total long-term debt			813,216	813,216	1,169,742
Less: current maturities of long-term debt			(1,884)	(1,884)	(20,872)
Long-term debt, excluding current maturities			$ 811,332	$ 811,332	$ 1,148,870
Weighted average effective interest rate			1.20%	1.20%	3.90%
MBFC loan
Long-term debt
Aggregate principal balance			$ 16,707	$ 16,707	$ 14,807
MBFC loan | LIBOR
Long-term debt
Interest rate				2%
MBFC loan | Base rate
Long-term debt
Interest rate				1%
Credit agreement
Long-term debt
Aggregate principal balance					1,158,000
Fixed rate debt					125,000
Credit agreement | Credit Agreement
Long-term debt
Aggregate principal balance			799,500	$ 799,500	1,158,000
Credit agreement | Credit Agreement | Revolving loan
Long-term debt
Aggregate principal balance			799,500	799,500	908,000
Fixed rate debt			125,000	125,000
Credit agreement | Credit Agreement | Secured Debt
Long-term debt
Aggregate principal balance			$ 0	$ 0	$ 250,000
Credit agreement | Minimum | LIBOR
Long-term debt
Interest rate			1%
Credit agreement | Minimum | Base rate
Long-term debt
Interest rate	0%	0%	0%
Credit agreement | Maximum | LIBOR
Long-term debt
Interest rate			2%
Credit agreement | Maximum | Base rate
Long-term debt
Interest rate	1%	1%	1%

Long-Term Debt - Aggregate annu

Long-Term Debt - Aggregate annual maturities (Details) - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Debt Disclosure [Abstract]
Fiscal 2023 (balance for remainder of fiscal year)	$ 3,125
Fiscal 2024	21,057
Fiscal 2025	6,250
Fiscal 2026	1,142,375
Fiscal 2027	0
Thereafter	0
Total	$ 1,172,807	$ 816,207

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) - USD ($)				3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 24, 2022	Jun. 28, 2022	Feb. 28, 2022	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021	Feb. 28, 2022
Debt Instrument [Line Items]
Interest costs incurred				$ 10,100,000	$ 3,300,000	$ 15,200,000	$ 6,300,000
Interest costs capitalized				900,000	$ 0	1,600,000	$ 0
Revolving loan
Debt Instrument [Line Items]
Maximum revolving commitment				1,250,000,000		1,250,000,000
Credit agreement
Debt Instrument [Line Items]
Maximum additional debt allowed in the event a qualified acquisition is consummated				265,200,000		265,200,000
Credit agreement | Minimum | Base rate
Debt Instrument [Line Items]
Interest rate	0%	0%	0%
Credit agreement | Minimum | SOFR
Debt Instrument [Line Items]
Interest rate		1%
Credit agreement | Minimum | LIBOR
Debt Instrument [Line Items]
Interest rate			1%
Credit agreement | Maximum | Base rate
Debt Instrument [Line Items]
Interest rate	1%	1%	1%
Credit agreement | Maximum | SOFR
Debt Instrument [Line Items]
Interest rate		2%
Credit agreement | Maximum | LIBOR
Debt Instrument [Line Items]
Interest rate			2%
Credit agreement | MBFC loan | SOFR
Debt Instrument [Line Items]
Credit spread for term SOFR borrowings	0.10%
Credit agreement | MBFC loan | Minimum | SOFR
Debt Instrument [Line Items]
Interest rate	1%
Credit agreement | MBFC loan | Maximum | SOFR
Debt Instrument [Line Items]
Interest rate	2%
Credit agreement | Credit Agreement | June 1, 2022 through February 28, 2023
Debt Instrument [Line Items]
Maximum net leverage ratio		4
Credit agreement | Credit Agreement | March 1, 2023 through May 31, 2023
Debt Instrument [Line Items]
Maximum net leverage ratio		3.75
Credit agreement | Credit Agreement | Thereafter
Debt Instrument [Line Items]
Maximum net leverage ratio		3.50
Credit agreement | Credit Agreement | SOFR
Debt Instrument [Line Items]
Credit spread for term SOFR borrowings		0.10%
Credit agreement | Letter of credit
Debt Instrument [Line Items]
Amount outstanding, letters of credit				17,700,000		17,700,000
Credit agreement | Revolving loan | Credit Agreement
Debt Instrument [Line Items]
Amount available for borrowings				$ 324,300,000		$ 324,300,000
Credit agreement | Secured Debt | Credit Agreement
Debt Instrument [Line Items]
Exercise of accordion agreement		$ 250,000,000
Percent of principal due quarterly		0.625%
MBFC loan | Base rate
Debt Instrument [Line Items]
Interest rate								1%
MBFC loan | LIBOR
Debt Instrument [Line Items]
Interest rate								2%

Fair Value (Details)

Fair Value (Details) - Recurring - Fair Values - Fair Value, Inputs, Level 2 - USD ($) $ in Thousands	Aug. 31, 2022	Feb. 28, 2022
Assets:
Total assets	$ 9,703	$ 3,356
Liabilities:
Total liabilities	193	3,606
Interest rate swaps
Assets:
Foreign currency derivatives	1,809	0
Liabilities:
Derivative liabilities	0	2,781
Foreign currency derivatives
Assets:
Foreign currency derivatives	7,439	2,918
Liabilities:
Derivative liabilities	193	825
Money market funds
Assets:
Cash equivalents (money market accounts)	$ 455	$ 438

Financial Instruments and Ris_3

Financial Instruments and Risk Management - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021	Feb. 28, 2022
Foreign Currency Risk and Currency Exchange Uncertainties
Aggregate principal balance	$ 1,172,807		$ 1,172,807		$ 816,207
Foreign currency derivatives | Cash flow hedges
Foreign Currency Risk and Currency Exchange Uncertainties
Net gain reported in AOCI to be reclassified			$ (8,600)
Period of reclassification to AOCI			12 months
Credit agreement
Foreign Currency Risk and Currency Exchange Uncertainties
Fixed rate debt	125,000		$ 125,000
Aggregate principal balance	1,158,000		1,158,000
SG&A
Foreign Currency Risk and Currency Exchange Uncertainties
Net foreign exchange gains (losses), including the impact of currency hedges and currency swaps	$ (2,700)	$ (900)	$ (2,500)	$ (500)
Net sales revenue | Geographic concentration | International operations - transactions denominated in foreign currencies
Foreign Currency Risk and Currency Exchange Uncertainties
Concentration risk percentage		9%	12%	10%

Financial Instruments and Ris_4

Financial Instruments and Risk Management - Derivative FV (Details) € in Thousands, £ in Thousands, kr in Thousands, $ in Thousands, $ in Thousands, $ in Thousands	Aug. 31, 2022 EUR (€)	Aug. 31, 2022 USD ($)	Aug. 31, 2022 CAD ($)	Aug. 31, 2022 GBP (£)	Aug. 31, 2022 AUD ($)	Aug. 31, 2022 NOK (kr)	Feb. 28, 2022 EUR (€)	Feb. 28, 2022 USD ($)	Feb. 28, 2022 CAD ($)	Feb. 28, 2022 GBP (£)	Feb. 28, 2022 AUD ($)
Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		$ 8,565						$ 2,918
Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		683						0
Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		193						2,271
Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						1,335
Derivatives designated as hedging instruments | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		8,565						2,918
Derivatives designated as hedging instruments | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		683						0
Derivatives designated as hedging instruments | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						1,559
Derivatives designated as hedging instruments | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						1,335
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | €	€ 20,900						€ 17,000
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		2,489						1,224
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Euros | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount			$ 39,050						$ 40,000
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		1,204						475
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		149						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Canadian Dollars | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | £				£ 18,410						£ 24,000
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		3,444						1,219
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Pounds | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount					$ 800						$ 5,700
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		18						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						113
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Australian Dollars | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | kr						kr 36,180
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		135
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0
Derivatives designated as hedging instruments | Foreign currency derivatives | Sell | Norwegian Kroner | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0
Derivatives designated as hedging instruments | Interest rate swaps
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount		125,000						125,000
Derivatives designated as hedging instruments | Interest rate swaps | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		1,275						0
Derivatives designated as hedging instruments | Interest rate swaps | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		534						0
Derivatives designated as hedging instruments | Interest rate swaps | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						1,446
Derivatives designated as hedging instruments | Interest rate swaps | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						1,335
Derivatives not designated under hedge accounting | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		193						712
Derivatives not designated under hedge accounting | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | €	€ 4,532						€ 6,000
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		74						244
Derivatives not designated under hedge accounting | Cross currency debt swaps | Euros | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds
Fair values of derivative instruments in the consolidated balance sheet
Notional Amount | £				£ 2,291						£ 4,500
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Prepaid Expenses and Other Current Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Assets
Fair values of derivative instruments in the consolidated balance sheet
Derivative assets		0						0
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Accrued Expenses and Other Current Liabilities
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		119						468
Derivatives not designated under hedge accounting | Cross currency debt swaps | Pounds | Other Liabilities, Non- current
Fair values of derivative instruments in the consolidated balance sheet
Derivative liabilities		$ 0						$ 0

Financial Instruments and Ris_5

Financial Instruments and Risk Management - Derivative Tax Effect (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	$ 7,649	$ 5,522	$ 12,174	$ 2,041
Gain (Loss) Reclassified from AOCI into Income	2,434	(2,211)	2,950	(4,721)
Gain (Loss)  Recognized in Income	(250)	469	625	338
Foreign currency derivatives | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	6,226	5,456	8,545	2,265
Foreign currency derivatives | Cash flow hedges | SG&A
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	2,715	(861)	3,911	(2,087)
Interest rate swaps | Cash flow hedges
Pre-tax effect of derivative instruments
Gain (Loss) Recognized in AOCI	1,423	66	3,629	(224)
Interest rate swaps | Cash flow hedges | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss) Reclassified from AOCI into Income	(281)	(1,350)	(961)	(2,634)
Cross currency debt swaps | SG&A
Pre-tax effect of derivative instruments
Gain (Loss)  Recognized in Income	0	469	875	340
Cross currency debt swaps | Interest expense
Pre-tax effect of derivative instruments
Gain (Loss)  Recognized in Income	0	0	0	(2)
Forward Contracts | SG&A
Pre-tax effect of derivative instruments
Gain (Loss)  Recognized in Income	$ (250)	$ 0	$ (250)	$ 0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Aug. 31, 2022	May 31, 2022	Aug. 31, 2021	May 31, 2021	Aug. 31, 2022	Aug. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,356,422	$ 1,327,339	$ 1,202,081	$ 1,239,347	$ 1,327,339	$ 1,239,347
Other comprehensive income before reclassification					12,174	2,041
Amounts reclassified out of AOCI					(2,950)	4,721
Tax effects					(2,226)	(1,317)
Total other comprehensive income, net of tax	3,839	3,159	6,242	(797)	6,998	5,445
Ending balance	1,398,346	1,356,422	1,267,822	1,202,081	1,398,346	1,267,822
Interest Rate Swaps
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		(2,126)		(7,576)	(2,126)	(7,576)
Other comprehensive income before reclassification					3,629	(224)
Amounts reclassified out of AOCI					961	2,634
Tax effects					(1,083)	(574)
Total other comprehensive income, net of tax					3,507	1,836
Ending balance	1,381		(5,740)		1,381	(5,740)
Foreign Currency Contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		2,328		(4,080)	2,328	(4,080)
Other comprehensive income before reclassification					8,545	2,265
Amounts reclassified out of AOCI					(3,911)	2,087
Tax effects					(1,143)	(743)
Total other comprehensive income, net of tax					3,491	3,609
Ending balance	5,819		(471)		5,819	(471)
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	3,361	202	(12,453)	(11,656)	202	(11,656)
Total other comprehensive income, net of tax	3,839	3,159	6,242	(797)
Ending balance	$ 7,200	$ 3,361	$ (6,211)	$ (12,453)	$ 7,200	$ (6,211)

Segment Information - Segment I

Segment Information - Segment Information by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Segment information
Sales revenue, net	$ 521,400	$ 475,228	$ 1,029,478	$ 1,016,451
Restructuring charges	4,776	369	4,778	375
Operating income (loss)	46,946	67,291	80,885	132,126
Capital and intangible asset expenditures	36,433	19,948	112,635	23,954
Depreciation and amortization	11,119	8,728	21,617	17,441
Home & Outdoor
Segment information
Sales revenue, net	240,559	215,218	474,822	408,862
Restructuring charges	472	369	472	369
Operating income (loss)	42,082	41,921	71,875	69,064
Capital and intangible asset expenditures	32,420	17,050	105,151	20,037
Depreciation and amortization	4,493	2,815	8,988	5,363
Health & Wellness
Segment information
Sales revenue, net	180,506	141,479	349,447	345,575
Restructuring charges	3,554	0	3,554	0
Operating income (loss)	(2,610)	4,794	(8,752)	16,043
Capital and intangible asset expenditures	2,810	2,232	4,439	2,980
Depreciation and amortization	3,021	2,624	5,833	5,350
Beauty
Segment information
Sales revenue, net	100,335	118,531	205,209	262,014
Restructuring charges	750	0	752	6
Operating income (loss)	7,474	20,576	17,762	47,019
Capital and intangible asset expenditures	1,203	666	3,045	937
Depreciation and amortization	$ 3,605	$ 3,289	$ 6,796	$ 6,728

Segment Information - Revenue b

Segment Information - Revenue by Domestic and International (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Segment information
Sales revenue, net	$ 521,400	$ 475,228	$ 1,029,478	$ 1,016,451
U.S. sales revenue, net
Segment information
Sales revenue, net	387,340	369,590	759,517	774,436
International sales revenue, net
Segment information
Sales revenue, net	$ 134,060	$ 105,638	$ 269,961	$ 242,015
Revenue from Contract with Customer Benchmark | Geographic concentration
Segment information
Concentration risk percentage	100%	100%	100%	100%
Revenue from Contract with Customer Benchmark | Geographic concentration | U.S. sales revenue, net
Segment information
Concentration risk percentage	74.30%	77.80%	73.80%	76.20%
Revenue from Contract with Customer Benchmark | Geographic concentration | International sales revenue, net
Segment information
Concentration risk percentage	25.70%	22.20%	26.20%	23.80%

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit) as a percent of income before income taxes	19.10%	19.80%	18.20%	14%

Earnings per Share (Details)

Earnings per Share (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Aug. 31, 2022	Aug. 31, 2021	Aug. 31, 2022	Aug. 31, 2021
Weighted average diluted securities
Weighted average shares outstanding, basic (in shares)	23,969	24,101	23,917	24,225
Incremental shares from share-based payment arrangements (in shares)	87	246	172	267
Weighted average shares outstanding, diluted (in shares)	24,056	24,347	24,089	24,492
Anti-dilutive securities
Weighted average diluted securities
Antidilutive securities (in shares)	54	29	42	15